JP2026503618A - Sarm1阻害剤としての置換された1h-ピラゾール-4-カルボキサミド - Google Patents

Sarm1阻害剤としての置換された1h-ピラゾール-4-カルボキサミド

Info

Publication number
JP2026503618A
JP2026503618A JP2025542419A JP2025542419A JP2026503618A JP 2026503618 A JP2026503618 A JP 2026503618A JP 2025542419 A JP2025542419 A JP 2025542419A JP 2025542419 A JP2025542419 A JP 2025542419A JP 2026503618 A JP2026503618 A JP 2026503618A
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
mmol
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025542419A
Other languages
English (en)
Japanese (ja)
Other versions
JP2026503618A5 (https=
Inventor
サイモン ブリアリー,アンドリュー
デブラジ,ラジェシュ
オーウェン ヒューズ,ロバート
アン パロット,シェリー
ボサナック,トッド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Disarm Therapeutics Inc
Original Assignee
Disarm Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Disarm Therapeutics Inc filed Critical Disarm Therapeutics Inc
Publication of JP2026503618A publication Critical patent/JP2026503618A/ja
Publication of JP2026503618A5 publication Critical patent/JP2026503618A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2025542419A 2023-01-24 2024-01-18 Sarm1阻害剤としての置換された1h-ピラゾール-4-カルボキサミド Pending JP2026503618A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202363481202P 2023-01-24 2023-01-24
US63/481,202 2023-01-24
PCT/US2024/011943 WO2024158607A1 (en) 2023-01-24 2024-01-18 Substituted 1h-pyrazole-4-carboxamides as sarm1 inhibitors

Publications (2)

Publication Number Publication Date
JP2026503618A true JP2026503618A (ja) 2026-01-29
JP2026503618A5 JP2026503618A5 (https=) 2026-02-24

Family

ID=89983825

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025542419A Pending JP2026503618A (ja) 2023-01-24 2024-01-18 Sarm1阻害剤としての置換された1h-ピラゾール-4-カルボキサミド

Country Status (6)

Country Link
EP (1) EP4655295A1 (https=)
JP (1) JP2026503618A (https=)
CN (1) CN120826394A (https=)
AR (1) AR131685A1 (https=)
TW (1) TW202444700A (https=)
WO (1) WO2024158607A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025243724A1 (ja) * 2024-05-20 2025-11-27 国立研究開発法人国立精神・神経医療研究センター 神経保護剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112839647B (zh) 2018-06-07 2025-09-23 达萨玛治疗公司 Sarm1抑制剂
WO2021142006A1 (en) 2020-01-07 2021-07-15 Disarm Therapeutics, Inc. Inhibitors of sarm1

Also Published As

Publication number Publication date
AR131685A1 (es) 2025-04-23
WO2024158607A1 (en) 2024-08-02
CN120826394A (zh) 2025-10-21
TW202444700A (zh) 2024-11-16
EP4655295A1 (en) 2025-12-03

Similar Documents

Publication Publication Date Title
AU2019283921B2 (en) Indole carboxamide compounds useful as kinase inhibitors
KR102793183B1 (ko) 헤테로시클릭 rip1 키나제 억제제
AU2017378324B2 (en) Bycyclic heteroaryl derivatives as CFTR potentiators
CN1795195B (zh) 新颖的吡啶并吡嗪及其作为激酶调节剂的用途
RS62987B1 (sr) Novi heterociklični derivati korisni kao shp2 inhibitori
CN108290897A (zh) 一类取代三唑并哌嗪类parp抑制剂及其制备方法和用途
AU2009345802B2 (en) Phenoxymethyl heterocyclic compounds
CA2930060A1 (en) Alkyl-amide-substituted pyridyl compounds useful as modulators of il-12, il-23 and/or ifnalpha responses
CA2770116A1 (en) Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
CN101646671A (zh) 用作蛋白激酶抑制剂的化合物
CA2633760A1 (en) Anti-viral compounds
WO2019101086A1 (zh) 卤代烯丙基胺类ssao/vap-1抑制剂及其应用
CZ20023945A3 (cs) Substituované pyrrolopyridinové deriváty pro použití jako inhibitory fosfodiesterázy
CN105722840B (zh) 作为PI3K、mTOR抑制剂的稠合喹啉化合物
TW201040191A (en) Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
CN101918079A (zh) 蛋白激酶抑制剂及其用途
JP2019509272A (ja) 脊髄性筋萎縮症の治療のための併用療法
CN113166105B (zh) 作为cdk-hdac双通路抑制剂的杂环化合物
JP2009524682A (ja) アナバシン誘導体、医薬組成物およびその使用方法
CN100402521C (zh) 4-咪唑啉-2-酮化合物
JP7577819B2 (ja) Ahrアゴニスト
JP2026503618A (ja) Sarm1阻害剤としての置換された1h-ピラゾール-4-カルボキサミド
WO2017073743A1 (ja) 三環性化合物
CN105294554B (zh) 苯基哌嗪衍生物及其使用方法和用途
CN101484457B (zh) 作为用于治疗增殖病症的蛋白激酶PLK1抑制剂的4,5-二氢-[1,2,4]三唑并[4,3-f]蝶啶

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260213

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260213